stockrowCellectis S.A. (CLLS) vs MediciNova, Inc. (MNOV)
- Cellectis S.A. CLLS 1.07 +3.88%
- MediciNova, Inc. MNOV 1.46 +0.69%
Cellectis S.A. and MediciNova, Inc. are both Biotechnology companies. Cellectis S.A. and MediciNova, Inc. are of similar size ($74.5M and $71.4M). Cellectis S.A. grew revenue faster over the last twelve months: 0.61% against −82.2%. Cellectis S.A. has the higher net margin (−102.3% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 17 metrics below, Cellectis S.A. leads on 9 and MediciNova, Inc. on 8.
Valuation
Profitability
| Metric | CLLS | MNOV | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 37.76% | 68.51% |
| Operating margin | (90.88%) | (1,287.53%) | 0.00% |
| Net margin | (102.34%) | (1,168.31%) | 0.00% |
| Free cash flow margin | (68.63%) | (991.31%) | 0.00% |
| Return on equity | (94.54%) | (25.56%) | (51.96%) |
| Return on assets | (21.02%) | (23.83%) | (46.06%) |
| Return on invested capital | 0.00% | (62.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack